Press Releases

SAN DIEGO, Oct. 16, 2019 /PRNewswire/ -- Insilico Medicine and ChemDiv, Inc. launched a new strategic collaboration to provide certain pharmaceutical and biotechnology companies with end-to-end drug discovery solutions. This collaboration combines the most advanced artificial intelligence (AI) techniques with a premium integrated drug discovery shared risk platform. The

SAN FRANCISCO, Oct. 16, 2019 /PRNewswire/ -- Today, CleanFund Commercial PACE Capital, Inc. ("CleanFund") announced funding $36 million in Commercial Property Assessed Cle

ALPHARETTA, Ga., Oct. 16, 2019 /PRNewswire/ -- Leading medical education consortium xMedica LLC is pleased to announce a new and expanded educational website featuring CME and non-CME programs for aesthe

SHANGHAI, Oct. 16, 2019 /PRNewswire/ -- Hepagene Therapeutics, Inc, a clinical stage drug discovery and development company which devotes its efforts towards discovering, developing and delivering innovative medicines that help patients prevail over liver diseases, announced today that it has dosed the first healthy volunteer in a phase I clinical trial of HPG1860 in

LAS VEGAS, Oct. 16, 2019 /PRNewswire/ -- GNCC Capital, Inc. (OTC: GNCP) ("The Company" or "GNCC") confirms that the related party transaction referred to October 10, 2019 has been ratified.Your recently appointed GNCC Directors confirm that at this time, GNCC will focus its activities in South Africa t

NORTH CHICAGO, Ill., Oct. 16, 2019 /PRNewswire/ -- In accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013, AbbVie Inc. confirms that as of October 14, 2019 its issued share capital, excluding treasury shares, is comprised of 1,478,820,152 shares of common stock with a par value of $0.01

EVANSTON, Ill., Oct. 16, 2019 /PRNewswire/ -- Recent research compiled by the American Massage Therapy Association on massage therapy for cancer patients continu

GENEVA, Oct. 16, 2019 /PRNewswire/ -- Andrew Alliance and Brooks Life Sciences today announced a co-marketing relationship that will enable Brooks Life Sciences consumables to be added to Andrew Alliance's groundbreaking OneLab software environment, developed to support the design, execution and sharing of lif

SHANGHAI, Oct. 16, 2019 /PRNewswire/ -- dMed Biopharmaceutical Co., Ltd. recently announced completion of a nearly US$50 million Series B financing, led by Vivo Capital and joined by Legend Capital, Qiming Venture Partners and Lilly Asia Ventures. After this round of financing, dMed will accelerate expansion of its comprehensive clinical ope

WASHINGTON, Oct. 16, 2019 /PRNewswire/ -- U.S. News & World Report, the global authority in hospital rankings and